View Item 

Show simple item record

Complement C5 and Early Oxygen Kinetics during Murine Sepsis

dc.contributor.authorValencia, Gabrielen_US
dc.contributor.authorSarma, J. Vidyaen_US
dc.contributor.authorYounger, John G.en_US
dc.date.accessioned2010-06-01T21:38:53Z
dc.date.available2010-06-01T21:38:53Z
dc.date.issued2005-04en_US
dc.identifier.citationValencia, Gabriel; Sarma, J. Vidya; Younger, John G. (2005). "Complement C5 and Early Oxygen Kinetics during Murine Sepsis." Academic Emergency Medicine 12(4): 275-281. <http://hdl.handle.net/2027.42/74696>en_US
dc.identifier.issn1069-6563en_US
dc.identifier.issn1553-2712en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74696
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15805316&dopt=citationen_US
dc.format.extent124959 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/octet-stream
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2005 Society for Academic Emergency Medicineen_US
dc.subject.otherOpen-circuit Calorimetryen_US
dc.subject.otherOxygen Consumptionen_US
dc.subject.otherRespiratory Exchange Ratioen_US
dc.subject.otherC5a, Anaphylatoxinen_US
dc.titleComplement C5 and Early Oxygen Kinetics during Murine Sepsisen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Emergency Medicine, University of Michigan, Ann Arbor, MI.en_US
dc.contributor.affiliationumDepartments of Pathology, University of Michigan, Ann Arbor, MI.en_US
dc.identifier.pmid15805316en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74696/1/j.aem.2004.10.025.pdf
dc.identifier.doi10.1197/j.aem.2004.10.025en_US
dc.identifier.sourceAcademic Emergency Medicineen_US
dc.identifier.citedreferenceAngus, DC, Linde-Zwirble, WT, Clermont, G, Carcillo, J, Pinksy, M. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29: 1303 – 10.en_US
dc.identifier.citedreferenceRivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 349: 1368 – 77.en_US
dc.identifier.citedreferenceMoriyama S, Okamoto K, Tabira Y et al. Evaluation of oxygen consumption and resting energy expenditure in critically ill patients with systemic inflammatory response syndrome. Crit Care Med. 1999; 27: 2133 – 6.en_US
dc.identifier.citedreferenceSiegel J, Cerra F, Coleman B et al. Physiologic and metabolic correlations in human sepsis. Surgery. 1979; 86: 163 – 93.en_US
dc.identifier.citedreferenceReiss M, Roos D. Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J Clin Invest. 1978; 61: 480 – 8.en_US
dc.identifier.citedreferenceWatts JA, Kline JA. Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury. Acad Emerg Med. 2003; 10: 985 – 97.en_US
dc.identifier.citedreferenceEbong, S, Call, D, Nemzek, J, Bolgos, G, Newcomb, D, Remick, D. Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun. 1999; 67: 6603 – 10.en_US
dc.identifier.citedreferenceLumb AB. Nunn's Applied Respiratory Physiology. Oxford, UK: Butterworth Heinemann, 2000.en_US
dc.identifier.citedreferenceHenderson B, Poole S, Wilson M. Bacteria and cytokines: beyond lipopolysaccharide. In: Bacteria–Cytokine Interactions in Health and Disease. Miami, FL: Portland Press, 1998, 211 – 80.en_US
dc.identifier.citedreferenceHenderson B, Poole S, Wilson M. Lipopolysaccharides and cytokines: a tangled web. In: Bacteria–Cytokine Interactions in Health and Disease. Miami, FL: Portland Press, 1998, pp 167 – 210.en_US
dc.identifier.citedreferenceBhole D, Stahl GL. Therapeutic potential of targeting the complement cascade in critical care medicine. Crit Care Med. 2003; 31 ( suppl ): S97 – S104.en_US
dc.identifier.citedreferenceWard PA. The darkside of C5a in sepsis. Nature Rev Immunol. 2004; 4: 133 – 42.en_US
dc.identifier.citedreferenceHopken, EU, Bao, L, Gerard, NP, Gerard, C. The C5a chemoattractant receptor mediates mucosal defense to infection. Nature. 1996; 383: 86 – 9.en_US
dc.identifier.citedreferenceYounger JG, Shankar-Sinha S, Mickiewicz M et al. Murine complement interactions with Pseudomonas aeruginosa and their effects during acute pneumonia. Am J Respir Cell Mol Biol. 2003; 29: 432 – 8.en_US
dc.identifier.citedreferenceCzermak BJ, Sarma V, Pierson CL et al. Protective effects of C5a blockade in sepsis. Nat Med. 1999; 5: 788 – 92.en_US
dc.identifier.citedreferenceYounger JG, Sasaki N, Delgado J et al. Systemic and lung physiological changes after intravascular activation of complement with cobra venom factor. J Appl Physiol. 2001; 90: 2289 – 95.en_US
dc.identifier.citedreferenceGuo RF, Huber-Lang M, Wang X et al. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest. 2000; 106: 1271 – 80.en_US
dc.identifier.citedreferenceHuber-Lang MS, Sarma JV, McGuire SR et al. Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J. 2001; 15: 568 – 70.en_US
dc.identifier.citedreferenceLaudes IJ, Chu JC, Sikranth S et al. Anti-C5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am J Pathol. 2002; 160: 1867 – 75.en_US
dc.identifier.citedreferenceWetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component (C5): a 2-base pair gene deletion in a 5′-exon. J Biol Chem. 1990; 265: 2435 – 40.en_US
dc.identifier.citedreferenceWheat, WH, Wetsel, R, Falus, A, Tack, BF, Strunk, RC. The fifth component of complement (C5) in the mouse: analysis of the molecular basis of deficiency. J Exp Med. 1987; 165: 1442 – 7.en_US
dc.identifier.citedreferenceRiedemann NC, Guo RF, Ne TA et al. Increased C5a receptor expression in sepsis. J Clin Invest. 2001; 110: 101 – 8.en_US
dc.identifier.citedreferenceYounger JG, Sasaki N, Waite MD et al. Detrimental effects of complement activation in hemorrhagic shock. J Appl Physiol. 2000; 90: 441 – 6.en_US
dc.identifier.citedreferenceShankar-Sinha S, Valencia GA, Janes BK et al. Klebsiella pneumoniae O-antigen contributes to bacteremia and lethality during murine pneumonia. Infect Immun. 2004; 72: 1423 – 30.en_US
dc.identifier.citedreferenceCerquetti, MC, Sordelli, DO, Bellanti, JA, Hooke, AM. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun. 1986; 52: 853 – 7.en_US
dc.identifier.citedreferenceRosenberg LT, Tachibana DK. Mice deficient in C5 Progr. Allergy. 1986; 39: 169 – 91.en_US
dc.identifier.citedreferenceHuber-Lang MS, Riedemann NC, Sarma JV et al. Protection of innate immunity by C5aR antagonist in septic mice. FASEB J. 2002; 16: 1567 – 74.en_US
dc.identifier.citedreferenceVerrier ED, Sherman SK, Taylor KM et al. Investigators Primo-CABG. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA. 2004; 291: 2319 – 27.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.aem.2004.10.025.pdf
Size:
122.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.